Sophie L. Gerritse

Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

Laura M. Legué, Nienke Bernards, Sophie L. Gerritse et al. · Acta Oncologica · 2016 · 96 citations · Full text

Medicine, Oncology, Surgery +16

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

Erik J. van Helden, Sjoerd G. Elias, Sophie L. Gerritse et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias et al. · Clinical Cancer Research · 2022 · 33 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results

Suzanne C. van Es, Bert van der Vegt, Frederike Bensch et al. · The American Journal of Surgical Pathology · 2019 · 31 citations · Full text

Medicine, Oncology, Breast Oncology +15

Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors

Maria Rovithi, Sophie L. Gerritse, Richard J. Honeywell et al. · Journal of Clinical Oncology · 2018 · 19 citations · Full text

Pharmacy, Oncology, Pharmacology +17